Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
6.00    0.00 (0.00%)
Bid:
5.50
Ask:
6.50
Spread: 1.00 (18.182%)
Market Cap: £15.44m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

19 Dec 2024 16:30

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, December 19

19 December 2024

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2024 (the “Period”).

Chairman’s Statement

Following the announcement with Marechale’s full year results released in August 2024, the market continues to remain challenging, particularly in the hospitality sector.

During the six months ended 31 October 2024, the Company generated gross profits of £103,468 (2023: £93,813) and delivered an operating loss of £138,485 (2023: loss of £155,421 ), resulting in an overall loss before tax of £178,261 (2023: loss of £155,803).

The Company’s balance sheet shows a net asset value of £3,183,537 (2023: £3,340,486 ), representing 3.01p (2023: 3.15p) of value per share in issue. The Company remains positive about the investments that it holds in its client companies.

Marechale Capital continues to see interesting corporate finance and advisory projects where it can take founders shares and warrants as part of its advisory fees. On a positive note, Marechale has completed transactions during the period for Weardale Lithium, Forest Road Brewery, Stubben Edge and Chestnut Inns. However, the market remains a difficult environment in which to raise capital. This has resulted in some advisory projects that launched in the summer not being completed by the end of the Period which includes a major UK hotel group and a leading brewery and pub group. Marechale continues to look for new and strategic funding partners alongside its traditional investor relationships.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals. The plan is to continue to develop Marechale’s strategic partnerships with the objective of enhancing shareholder value.

Marechale also uses its balance sheet to co-invest in its client companies, along with warrants and founder equity. Furthermore, the Board is able to announce a partial realisation of £109,000 for cash on two of the Company’s investments. Cash at bank at 31 October 2024 was £223,700.

Whist the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Income Statement (unaudited)
6 months ended 31 October20242023
£
Revenue148,500320,603
Cost of sales(45,032)(226,790)
Gross profit 103,46893,813
Administrative expenses(241,953)(249,235)
Operating loss(138,485)(155,421)
Exceptional credit10,316-
Loss on disposal of investments(49,837)
Interest paid(255)(382)
(Loss)/profit before tax(178,261)(155,803)
Taxation--
(Loss)/profit after tax(178,261)(155,803)
(Loss)/profit per share
(Pence)(Pence)
- Basic(0.17)(0.15)
- Diluted(0.17)(0.14)
Balance Sheet (unaudited)
As at31 October31 October
20242023
Current assets
Available for sale investments2,939,6602,863,227
Trading investments49,953130,076
Trade and other receivables52,85637,219
Cash and cash equivalents223,712398,229
3,266,1813,428,751
Current liabilities
Trade and other payablesPAYEBounce-back Loan(54,338)(10,806)(10,000)(51,278)(9,847)(10,000)
Total current liabilities(75,144)(70,765)
Net current assets3,191,0373,357,986
Bounce-back Loan – long-term(7,500)(17,500)
Net assets3,183,5373,340,486
Equity
Capital and reserves attributable to equity shareholders
Share capitalShare premium847,530481,290847,530481,290
Reserve for own shares(50,254)(50,254)
Retained profits/ (losses)1,739,3971944,842
Reserve for share based payments165,574117,078
3,183,5373,340,486
Cash Flow Statement (unaudited)
6 months ended31 October31 October
20242023
££
Net cash from operating activities
Loss after tax (178,261)(155,803)
Reverse exceptional credits(10,316)-
Loss of disposal of investments49,837
Provision for share based paymentsReverse interest paid15,40625533,091381
Operating cash flows before movements in working capital(123,079)(122,331)
Movement in working capital
(Increase)/ decrease in receivables(7,950)38,714
Increase/ (decrease) in payables3,108(30,795)
Net movement in working capital(4,842)7,919
Operating cash out-flow(127,921)(114,412)
Investment activities
Expenditure on available for sale investments-572
Proceeds from sale of investments and options108,692-
Cash flow from investing activities108,692(572)
FinancingShare CapitalBounce-back Loan repaymentsInterest paidNet financing-(5,000)(255)(5,255)235,800(5,000)(381)230,419
Net (decrease)/ increase in cash and cash equivalents(24,484)115,435
Cash and cash equivalents at start of the period248,196282,794
Cash and cash equivalents at end of the period223,712398,229
(Decrease)/ increase in cash and cash equivalents(24,484)115,435

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
22nd Mar 20122:53 pmRNSHolding(s) in Company
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.